Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist

被引：0
|
作者：
Benjamin Berger
Jasper Dingemanse
Giancarlo Sabattini
Stéphane Delahaye
Urs Duthaler
Clemens Muehlan
Stephan Krähenbühl
机构：
[1] Idorsia Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] Idorsia Pharmaceuticals Ltd,Department of Preclinical Drug Metabolism and Pharmacokinetics
[3] University Hospital Basel,Division of Clinical Pharmacology and Toxicology
[4] University of Basel,Department of Biomedicine
来源：
Clinical Pharmacokinetics | 2021年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1349 / 1360
页数：11
相关论文
共 50 条
  • [21] Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
    Catherine Roch
    Giorgio Bergamini
    Michel A. Steiner
    Martine Clozel
    Psychopharmacology, 2021, 238 : 2693 - 2708
  • [22] Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist
    Bettica, Paolo
    Nucci, Gianluca
    Pyke, Caroline
    Squassante, Lisa
    Zamuner, Stefano
    Ratti, Emiliangelo
    Gomeni, Roberto
    Alexander, Robert
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (08) : 1058 - 1070
  • [23] Transfer of the Dual Orexin Receptor Antagonist Daridorexant into Breast Milk of Healthy Lactating Women
    Kaufmann, Priska
    Muehlan, Clemens
    Anliker-Ort, Marion
    Sabattini, Giancarlo
    Siebers, Nicholas
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (10): : 1278 - 1287
  • [24] EXCRETION OF THE DUAL OREXIN RECEPTOR ANTAGONIST DARIDOREXANT INTO BREAST MILK OF HEALTHY LACTATING WOMEN
    Kaufmann, Priska
    Anliker-Ort, Marion
    Siebers, Nicholas
    Muehlan, Clemens
    Dingemanse, Jasper
    SLEEP, 2024, 47
  • [25] Excretion of the dual orexin receptor antagonist daridorexant into breast milk of healthy lactating women
    Kaufmann, Priska
    Anliker-Ort, Marion
    Siebers, Nicholas
    Muehlan, Clemens
    Dingemanse, Jasper
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [26] Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects
    Berger, Benjamin
    Kornberger, Ruediger
    Dingemanse, Jasper
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : 90 - 104
  • [27] Abuse potential assessment of the novel dual orexin receptor antagonist daridorexant compared to suvorexant and zolpidem in recreational drug users
    Ufer, M.
    Kelsh, D.
    Schoedel, K.
    Dingemanse, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S21 - S22
  • [28] A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
    Ziemichod, Wojciech
    Grabowska, Karolina
    Kurowska, Antonina
    Biala, Grazyna
    MOLECULES, 2022, 27 (18):
  • [29] Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
    Cicala, Giuseppe
    Barbieri, Maria Antonietta
    Russo, Giulia
    Salvo, Francesco
    Spina, Edoardo
    PHARMACEUTICALS, 2024, 17 (03)
  • [30] EFFECT OF THE NOVEL DUAL OREXIN RECEPTOR ANTAGONIST DARIDOREXANT ON NIGHTTIME RESPIRATORY FUNCTION AND SLEEP IN PATIENTS WITH MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
    Boof, M.
    Dingemanse, J.
    Brunke, M.
    Esselmann, A.
    Heymer, P.
    Kestermann, O.
    Lederer, K.
    Fietze, I.
    Ufer, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S5 - S6
12345